<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Pathog</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Pathog</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plospath</journal-id><journal-title-group><journal-title>PLoS Pathogens</journal-title></journal-title-group><issn pub-type="ppub">1553-7366</issn><issn pub-type="epub">1553-7374</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5542374</article-id><article-id pub-id-type="doi">10.1371/journal.ppat.1006432</article-id><article-id pub-id-type="publisher-id">PPATHOGENS-D-17-00708</article-id><article-categories><subj-group subj-group-type="heading"><subject>Opinion</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Viral Diseases</subject><subj-group><subject>Influenza</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immunity</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immunity</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Orthomyxoviruses</subject><subj-group><subject>Influenza Viruses</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Orthomyxoviruses</subject><subj-group><subject>Influenza Viruses</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Orthomyxoviruses</subject><subj-group><subject>Influenza Viruses</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Orthomyxoviruses</subject><subj-group><subject>Influenza Viruses</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Microbial Evolution</subject><subj-group><subject>Viral Evolution</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Evolutionary Biology</subject><subj-group><subject>Organismal Evolution</subject><subj-group><subject>Microbial Evolution</subject><subj-group><subject>Viral Evolution</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Virology</subject><subj-group><subject>Viral Evolution</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Serology</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Evolutionary Biology</subject><subj-group><subject>Evolutionary Immunology</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and Places</subject><subj-group><subject>Population Groupings</subject><subj-group><subject>Age Groups</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pulmonology</subject><subj-group><subject>Respiratory Infections</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>The role of human immunity and social behavior in shaping influenza evolution</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8814-9421</contrib-id><name><surname>Kucharski</surname><given-names>Adam J.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3867-1953</contrib-id><name><surname>Baguelin</surname><given-names>Marc</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene &#x00026; Tropical Medicine, London, United Kingdom</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Respiratory Diseases Department, Public Health England, London, United Kingdom</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Coyne</surname><given-names>Carolyn B</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>University of Pittsburgh, UNITED STATES</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>adam.kucharski@lshtm.ac.uk</email></corresp></author-notes><pub-date pub-type="epub"><day>3</day><month>8</month><year>2017</year></pub-date><pub-date pub-type="collection"><month>8</month><year>2017</year></pub-date><volume>13</volume><issue>8</issue><elocation-id>e1006432</elocation-id><permissions><copyright-statement>&#x000a9; 2017 Kucharski, Baguelin</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Kucharski, Baguelin</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="ppat.1006432.pdf"/><funding-group><funding-statement>AJK was supported by a Medical Research Council fellowship (MR/K021524/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="2"/><table-count count="0"/><page-count count="5"/></counts></article-meta></front><body><p>Understanding the emergence of new influenza strains is crucial for seasonal vaccine strain selection and for assessing pandemic risk [<xref rid="ppat.1006432.ref001" ref-type="bibr">1</xref>,<xref rid="ppat.1006432.ref002" ref-type="bibr">2</xref>]. In particular, recent mismatches between vaccine composition strains and subsequent circulating viruses have led to low vaccine effectiveness and highlighted the need for improved predictions about which antigenic variants will be dominant during future epidemics [<xref rid="ppat.1006432.ref003" ref-type="bibr">3</xref>]. During the process of selecting vaccine strains from candidate circulating strains, sequence data can provide an indirect measurement of viral transmission fitness by revealing which new genetic variants have successfully become fixed globally [<xref rid="ppat.1006432.ref002" ref-type="bibr">2</xref>,<xref rid="ppat.1006432.ref004" ref-type="bibr">4</xref>]. Moreover, recent work has shown the importance of age-specific mixing and travel patterns in shaping the global circulation of influenza strains [<xref rid="ppat.1006432.ref005" ref-type="bibr">5</xref>]. Current influenza surveillance also includes analysis of epidemiological dynamics, with local outbreaks used as a proxy for transmissibility of viruses [<xref rid="ppat.1006432.ref002" ref-type="bibr">2</xref>]. However, the relationship between influenza transmission dynamics, population herd immunity, and viral evolution remains poorly understood. Specifically, there is a need to understand how selection pressure imposed via population-level immunity and transmission combine to shape the observed evolution of influenza viruses (<xref ref-type="fig" rid="ppat.1006432.g001">Fig 1</xref>).</p><fig id="ppat.1006432.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1006432.g001</object-id><label>Fig 1</label><caption><title>Influenza immunological, epidemiological, and evolutionary dynamics.</title><p>Influenza undergoes antigenic evolution over time, escaping prior immunity and generating new epidemics. These epidemics can in turn give rise to new strains. To fully understand the dynamics of such infections, it is therefore important to consider the interactions between these 3 processes. Illustrative figures shown for influenza A/H3N2: (A) global phylogeny [<xref rid="ppat.1006432.ref025" ref-type="bibr">25</xref>], (B) proportion of individuals with detectable titers in China [<xref rid="ppat.1006432.ref026" ref-type="bibr">26</xref>], and (C) clinical reports in the United Kingdom [<xref rid="ppat.1006432.ref014" ref-type="bibr">14</xref>].</p></caption><graphic xlink:href="ppat.1006432.g001"/></fig><p>In recent years, considerable resources have been committed to better monitor influenza evolution and resulting global diversity, most notably through the development of national influenza centers, with around 150 countries currently participating [<xref rid="ppat.1006432.ref006" ref-type="bibr">6</xref>]. This effort has resulted in a wealth of data being accumulated, in particular, genetic sequences. During the same period, serology has increasingly been employed to measure individual immunity against specific influenza strains [<xref rid="ppat.1006432.ref007" ref-type="bibr">7</xref>,<xref rid="ppat.1006432.ref008" ref-type="bibr">8</xref>], and there have been calls for a &#x0201c;World Serology Bank&#x0201d; to curate such data [<xref rid="ppat.1006432.ref009" ref-type="bibr">9</xref>]. Studies of social mixing patterns have also started to elucidate the role of age-specific social contacts in the transmission of respiratory infections [<xref rid="ppat.1006432.ref010" ref-type="bibr">10</xref>&#x02013;<xref rid="ppat.1006432.ref012" ref-type="bibr">12</xref>].</p><p>Given this growth in data, there is now potential to develop a comprehensive framework to bring disparate data streams together to jointly analyze influenza evolution, immunity, and transmission. For example, how do antigenic drift, herd immunity, and human behavior combine to influence outbreaks? Although patterns of cross-reactive antibody responses against circulating influenza viruses have been well characterized [<xref rid="ppat.1006432.ref013" ref-type="bibr">13</xref>] and the landscape of antibody responses can be mapped at the individual host level [<xref rid="ppat.1006432.ref007" ref-type="bibr">7</xref>], it has been challenging to estimate the population-level transmission potential of a specific virus from available data. Previous infections may generate cross-protective responses against related influenza strains, which will in turn reduce the transmissibility of such strains within a population. However, there is currently a critical link missing between the measurement of individual serological responses and analytic tools to predict transmission dynamics.</p><p>Influenza transmission depends both on the extent of cross-protective immunity within a population&#x02014;which is likely to vary between different age groups&#x02014;and transmission-relevant contact patterns within and between those groups. For example, younger age groups typically have higher antibody titers against recent influenza strains compared to older individuals [<xref rid="ppat.1006432.ref008" ref-type="bibr">8</xref>] but also have more social contacts [<xref rid="ppat.1006432.ref011" ref-type="bibr">11</xref>]. Faced with a novel infection, children would be expected to contribute most to transmission, but this may not be the case if they had preexisting immunity to a homologous or related strain [<xref rid="ppat.1006432.ref014" ref-type="bibr">14</xref>]. The overall transmission potential of an infection in a population can be measured using the effective reproduction number, R, defined as the average number of secondary cases generated by a typical infectious individual, which incorporates information about both population immunity and infectious contacts.</p><p>The increasing availability of serological and social-contact data presents an opportunity to combine immunological and epidemiological dynamics to estimate the overall transmission potential of different strains. To illustrate how such an analysis could be implemented, we combined publicly available serological and social-contact data from southern China to estimate the R of different strains of influenza A/H3N2 in 2009. R also provides a threshold value that characterizes the ability of a particular infection to spread in a population with preexisting immunity: for R values above 1, strains have epidemic potential. In the China data, the under-20-years-old age group had high titers on average against recent isolates (<xref ref-type="fig" rid="ppat.1006432.g002">Fig 2A</xref>), whereas the older age group had a different immunity profile, with lower average titers and most immunity against strains further in the past (<xref ref-type="fig" rid="ppat.1006432.g002">Fig 2B</xref>). The values of R for strains at different points in the A/H3N2 antigenic space were calculated by converting the under- and over-20 immune profiles into measures of age-specific susceptibility [<xref rid="ppat.1006432.ref015" ref-type="bibr">15</xref>], then combining these susceptibility estimates with the social mixing patterns of the 2 age groups. The resulting transmission fitness landscape indicated there were 2 regions of antigenic space that contain strains with high fitness, 1 near strains that circulated in the 1970s and 1 near the most recent isolates (<xref ref-type="fig" rid="ppat.1006432.g002">Fig 2C</xref>).</p><fig id="ppat.1006432.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1006432.g002</object-id><label>Fig 2</label><caption><title>Using serology and social contacts to explore the evolutionary dynamics of influenza A/H3N2.</title><p>(A, B) Mean log neutralization titer in age &#x0003c;20 and 20+ groups measured in 2009 against 9 strains in different antigenic locations, calculated using an &#x0201c;antibody landscape&#x0201d; smoothing technique [<xref rid="ppat.1006432.ref007" ref-type="bibr">7</xref>]. Data from 151 individuals in Guangdong, China [<xref rid="ppat.1006432.ref008" ref-type="bibr">8</xref>,<xref rid="ppat.1006432.ref026" ref-type="bibr">26</xref>]; year labels show antigenic location of the 9 test strains used to estimate the landscape. (C) Log titers can be converted into the proportion of each group susceptible against each strain [<xref rid="ppat.1006432.ref015" ref-type="bibr">15</xref>] and combining with age-stratified social-contact data [<xref rid="ppat.1006432.ref011" ref-type="bibr">11</xref>] to calculate the effective reproduction number (defined as the average number of secondary cases generated by a typical infectious host) for each strain location. (D) Effective reproduction number for different strains in antigenic space. Black dots show locations of strains that circulated in the 2 years after serological samples were collected (i.e., 2009&#x02013;2011) [<xref rid="ppat.1006432.ref007" ref-type="bibr">7</xref>]. The basic reproduction number (i.e., the average number of secondary cases generated by a typical infectious host in a fully susceptible population) is assumed to be 2. Code and data are available at: <ext-link ext-link-type="uri" xlink:href="https://github.com/adamkucharski/antigenic-evo">https://github.com/adamkucharski/antigenic-evo</ext-link>.</p></caption><graphic xlink:href="ppat.1006432.g002"/></fig><p>In this example, post-2009 influenza isolates (shown as black dots) were generally located in the higher-fitness region predicted by the model. The correspondence between the fitness landscape and future isolates in this simple illustration indicates that the new emerging strains were correctly characterized as having a higher transmission potential. This approach could also quantify the risk posed by previously circulating strains: the 2009 influenza A/H1N1p virus, which was antigenically similar to pre-1957 strains, could spread because there was not sufficient humoral immunity in younger age groups [<xref rid="ppat.1006432.ref016" ref-type="bibr">16</xref>,<xref rid="ppat.1006432.ref017" ref-type="bibr">17</xref>]; there has also been concern about influenza A/H2N2, which has not circulated in humans since 1968 [<xref rid="ppat.1006432.ref018" ref-type="bibr">18</xref>]. Similarly, the results in <xref ref-type="fig" rid="ppat.1006432.g002">Fig 2</xref> suggest that some pre-1979 A/H3N2 strains could have high transmissibility if reintroduced into a contemporary population. As well as identifying possible reemergence of homosubtypic pandemic viruses, the landscape of transmission fitness for seasonal influenza strains could also provide information about the potential emergence of novel influenza viruses, as there could be cross-protective responses against novel viruses within the same phylogenetic group [<xref rid="ppat.1006432.ref019" ref-type="bibr">19</xref>,<xref rid="ppat.1006432.ref020" ref-type="bibr">20</xref>].</p><p>A limitation of the example shown in <xref ref-type="fig" rid="ppat.1006432.g002">Fig 2</xref> is that the serological data are cross sectional and only capture population immunity when samples were taken in 2009. There is also evidence that specificity of immune responses can vary with age [<xref rid="ppat.1006432.ref021" ref-type="bibr">21</xref>,<xref rid="ppat.1006432.ref022" ref-type="bibr">22</xref>], with certain cohorts having monoclonal antibodies that target different antigenic sites to other groups; this may further shape the emergence and circulation of drifted viruses during an influenza season. The next step would be to link longitudinal serology with mathematical models of infection and antibody responses to explore how the landscape of population immunity accumulates over time. This would also make it possible to &#x0201c;rewind&#x0201d; history by removing recent periods of infection from the modelled immune landscapes and hence generate estimates for the historical fitness of specific influenza strains.</p><p>Such analysis could bring key scientific and public health benefits. First, it could lead to local risk mapping for novel influenza strains. Using serological and social-contact data in conjunction with mechanistic models, it would be possible to map herd immunity and transmission potential in different age groups and identify potential &#x0201c;blind spots&#x0201d; against specific strains [<xref rid="ppat.1006432.ref023" ref-type="bibr">23</xref>]. This could help quantify how the background of population immunity influences the effectiveness of repeated vaccination in the context of existing national immunization campaigns. Second, the analysis could reveal which strains pose the greatest epidemic risk and hence which viruses vaccination may need to target. In future, this could lay the foundations for &#x0201c;personalized immunization&#x0201d; strategies [<xref rid="ppat.1006432.ref024" ref-type="bibr">24</xref>], which would aim to increase vaccine effectiveness by employing different vaccine compositions depending on age and location. Third, by comparing estimates of historical influenza fitness landscapes to the observed trajectory of influenza antigenic evolution, it would be possible to establish what factors are most important in driving the emergence of new strains. In particular, there is potential to understand whether certain age groups and geographic locations contribute disproportionately to the selection pressure acting on circulating influenza viruses and hence what forms of surveillance would enable influenza evolution to be predicted more accurately in future.</p></body><back><ref-list><title>References</title><ref id="ppat.1006432.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Lipsitch</surname><given-names>M</given-names></name>, <name><surname>Barclay</surname><given-names>W</given-names></name>, <name><surname>Raman</surname><given-names>R</given-names></name>, <name><surname>Russell</surname><given-names>CJ</given-names></name>, <name><surname>Belser</surname><given-names>JA</given-names></name>, <name><surname>Cobey</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Viral factors in influenza pandemic risk assessment</article-title>. <source>eLife</source>
<year>2016</year>;<volume>5</volume>:<fpage>e18491</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7554/eLife.18491">10.7554/eLife.18491</ext-link></comment>
<?supplied-pmid 27834632?><pub-id pub-id-type="pmid">27834632</pub-id></mixed-citation></ref><ref id="ppat.1006432.ref002"><label>2</label><mixed-citation publication-type="other">World Health Organization. Recommended composition of influenza virus vaccines for use in the 2017&#x02013;2018 northern hemisphere influenza season. <ext-link ext-link-type="uri" xlink:href="http://www.who.int/influenza/vaccines/virus/recommendations/2017_18_north/en/">http://www.who.int/influenza/vaccines/virus/recommendations/2017_18_north/en/</ext-link></mixed-citation></ref><ref id="ppat.1006432.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Marill</surname><given-names>MC</given-names></name>. <article-title>After flu vaccine mismatch, calls for delayed selection intensify</article-title>. <source>Nature Medicine</source>
<year>2015</year>;<volume>21</volume>:<fpage>297</fpage>&#x02013;<lpage>298</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nm0415-297">10.1038/nm0415-297</ext-link></comment>
<?supplied-pmid 25849262?><pub-id pub-id-type="pmid">25849262</pub-id></mixed-citation></ref><ref id="ppat.1006432.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Neher</surname><given-names>RA</given-names></name>, <name><surname>Russell</surname><given-names>CA</given-names></name>, <name><surname>Shraiman</surname><given-names>BI</given-names></name>. <article-title>Predicting evolution from the shape of genealogical trees</article-title>. <source>eLife</source>;<year>2014</year>:<volume>3</volume></mixed-citation></ref><ref id="ppat.1006432.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Bedford</surname><given-names>T</given-names></name>, <name><surname>Riley</surname><given-names>S</given-names></name>, <name><surname>Barr</surname><given-names>IG</given-names></name>, <name><surname>Broor</surname><given-names>S</given-names></name>, <name><surname>Chadha</surname><given-names>M</given-names></name>, <name><surname>Cox</surname><given-names>NJ</given-names></name>, <etal>et al</etal>
<article-title>Global circulation patterns of seasonal influenza viruses vary with antigenic drift</article-title>. <source>Nature</source>
<year>2015</year>;<volume>523</volume>:<fpage>217</fpage>&#x02013;<lpage>20</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature14460">10.1038/nature14460</ext-link></comment>
<?supplied-pmid 26053121?><pub-id pub-id-type="pmid">26053121</pub-id></mixed-citation></ref><ref id="ppat.1006432.ref006"><label>6</label><mixed-citation publication-type="other">World Health Organization. List of National Influenza Centres. <ext-link ext-link-type="uri" xlink:href="http://www.who.int/influenza/gisrs_laboratory/national_influenza_centres/en/">http://www.who.int/influenza/gisrs_laboratory/national_influenza_centres/en/</ext-link></mixed-citation></ref><ref id="ppat.1006432.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Fonville</surname><given-names>J</given-names></name>, <name><surname>Wilks</surname><given-names>S</given-names></name>, <name><surname>James</surname><given-names>S</given-names></name>, <name><surname>Fox</surname><given-names>A</given-names></name>, <name><surname>Ventresca</surname><given-names>M</given-names></name>, <name><surname>Aban</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Antibody landscapes after influenza virus infection or vaccination</article-title>. <source>Science</source>
<year>2014</year>;<volume>346</volume>:<fpage>996</fpage>&#x02013;<lpage>1000</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.1256427">10.1126/science.1256427</ext-link></comment>
<?supplied-pmid 25414313?><pub-id pub-id-type="pmid">25414313</pub-id></mixed-citation></ref><ref id="ppat.1006432.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Lessler</surname><given-names>J</given-names></name>, <name><surname>Riley</surname><given-names>S</given-names></name>, <name><surname>Read</surname><given-names>JM</given-names></name>, <name><surname>Wang</surname><given-names>S</given-names></name>, <name><surname>Zhu</surname><given-names>H</given-names></name>, <name><surname>Smith</surname><given-names>GJD</given-names></name>, <etal>et al</etal>
<article-title>Evidence for Antigenic Seniority in Influenza A (H3N2) Antibody Responses in Southern China</article-title>. <source>PLoS Pathog</source>
<year>2012</year>;<volume>8</volume>:<fpage>e1002802</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.ppat.1002802">10.1371/journal.ppat.1002802</ext-link></comment>
<?supplied-pmid 22829765?><pub-id pub-id-type="pmid">22829765</pub-id></mixed-citation></ref><ref id="ppat.1006432.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Metcalf</surname><given-names>CJE</given-names></name>, <name><surname>Farrar</surname><given-names>J</given-names></name>, <name><surname>Cutts</surname><given-names>FT</given-names></name>, <name><surname>Basta</surname><given-names>NE</given-names></name>, <name><surname>Graham</surname><given-names>AL</given-names></name>, <name><surname>Lessler</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Use of serological surveys to generate key insights into the changing global landscape of infectious disease</article-title>. <source>The Lancet</source>
<year>2016</year>;<volume>388</volume>:<fpage>728</fpage>&#x02013;<lpage>30</lpage></mixed-citation></ref><ref id="ppat.1006432.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Mossong</surname><given-names>J</given-names></name>, <name><surname>Hens</surname><given-names>N</given-names></name>, <name><surname>Jit</surname><given-names>M</given-names></name>, <name><surname>Beutels</surname><given-names>P</given-names></name>, <name><surname>Auranen</surname><given-names>K</given-names></name>, <name><surname>Mikolajczyk</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>Social contacts and mixing patterns relevant to the spread of infectious diseases</article-title>
<source>PLoS Med</source>
<year>2008</year>;<volume>5</volume>:<fpage>e74</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pmed.0050074">10.1371/journal.pmed.0050074</ext-link></comment>
<?supplied-pmid 18366252?><pub-id pub-id-type="pmid">18366252</pub-id></mixed-citation></ref><ref id="ppat.1006432.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Read</surname><given-names>JM</given-names></name>, <name><surname>Lessler</surname><given-names>J</given-names></name>, <name><surname>Riley</surname><given-names>S</given-names></name>, <name><surname>Wang</surname><given-names>S</given-names></name>, <name><surname>Tan</surname><given-names>LJ</given-names></name>, <name><surname>Kwok</surname><given-names>KO</given-names></name>, <etal>et al</etal>
<article-title>Social mixing patterns in rural and urban areas of southern China</article-title>. <source>Proc R Soc B</source>
<year>2014</year>;<volume>281</volume>:<fpage>20140268</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1098/rspb.2014.0268">10.1098/rspb.2014.0268</ext-link></comment>
<?supplied-pmid 24789897?><pub-id pub-id-type="pmid">24789897</pub-id></mixed-citation></ref><ref id="ppat.1006432.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Kucharski</surname><given-names>AJ</given-names></name>, <name><surname>Kwok</surname><given-names>KO</given-names></name>, <name><surname>Wei</surname><given-names>VWI</given-names></name>, <name><surname>Cowling</surname><given-names>BJ</given-names></name>, <name><surname>Read</surname><given-names>JM</given-names></name>, <name><surname>Lessler</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>The Contribution of Social Behaviour to the Transmission of Influenza A in a Human Population</article-title>. <source>PLoS Pathog</source>
<year>2014</year>;<volume>10</volume>:<fpage>e1004206</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.ppat.1004206">10.1371/journal.ppat.1004206</ext-link></comment>
<?supplied-pmid 24968312?><pub-id pub-id-type="pmid">24968312</pub-id></mixed-citation></ref><ref id="ppat.1006432.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>DJ</given-names></name>, <name><surname>Lapedes</surname><given-names>AS</given-names></name>, <name><surname>de Jong</surname><given-names>JC</given-names></name>, <etal>et al</etal>
<article-title>Mapping the Antigenic and Genetic Evolution of Influenza Virus</article-title>. <source>Science</source>
<year>2004</year>;<volume>305</volume>:<fpage>371</fpage>&#x02013;<lpage>376</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.1097211">10.1126/science.1097211</ext-link></comment>
<?supplied-pmid 15218094?><pub-id pub-id-type="pmid">15218094</pub-id></mixed-citation></ref><ref id="ppat.1006432.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Baguelin</surname><given-names>M</given-names></name>, <name><surname>Flasche</surname><given-names>S</given-names></name>, <name><surname>Camacho</surname><given-names>A</given-names></name>, <name><surname>Demiris</surname><given-names>N</given-names></name>, <name><surname>Miller</surname><given-names>E</given-names></name>, <name><surname>Edmunds</surname><given-names>WJ</given-names></name>. <article-title>Assessing Optimal Target Populations for Influenza Vaccination Programmes: An Evidence Synthesis and Modelling Study</article-title>. <source>PLoS Med</source>
<year>2013</year>;<volume>10</volume>:<fpage>e1001527</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pmed.1001527">10.1371/journal.pmed.1001527</ext-link></comment>
<?supplied-pmid 24115913?><pub-id pub-id-type="pmid">24115913</pub-id></mixed-citation></ref><ref id="ppat.1006432.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Coudeville</surname><given-names>L</given-names></name>, <name><surname>Bailleux</surname><given-names>F</given-names></name>, <name><surname>Riche</surname><given-names>B</given-names></name>, <name><surname>Megas</surname><given-names>F</given-names></name>, <name><surname>Andre</surname><given-names>P</given-names></name>, <name><surname>Ecochard</surname><given-names>R</given-names></name>. <article-title>Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model</article-title>. <source>BMC Med Res Methodol</source>
<year>2010</year>;<volume>10</volume></mixed-citation></ref><ref id="ppat.1006432.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Xu</surname><given-names>R</given-names></name>, <name><surname>Ekiert</surname><given-names>DC</given-names></name>, <name><surname>Krause</surname><given-names>JC</given-names></name>, <name><surname>Hai</surname><given-names>R</given-names></name>, <name><surname>Crowe</surname><given-names>JEJ</given-names></name>, <name><surname>Wilson</surname><given-names>IA</given-names></name>. <article-title>Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus</article-title>. <source>Science</source>. <year>2010</year>;<volume>328</volume>(<issue>5976</issue>):<fpage>357</fpage>&#x02013;<lpage>360</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.1186430">10.1126/science.1186430</ext-link></comment>
<?supplied-pmid 20339031?><pub-id pub-id-type="pmid">20339031</pub-id></mixed-citation></ref><ref id="ppat.1006432.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Hancock</surname><given-names>K</given-names></name>, <name><surname>Veguilla</surname><given-names>V</given-names></name>, <name><surname>Lu</surname><given-names>X</given-names></name>, <name><surname>Zhong</surname><given-names>W</given-names></name>, <name><surname>Butler</surname><given-names>EN</given-names></name>, <name><surname>Sun</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus</article-title>. <source>N Engl J Med</source>
<year>2009</year>;<volume>20361</volume>(<issue>12</issue>):<fpage>1945</fpage>&#x02013;<lpage>52</lpage></mixed-citation></ref><ref id="ppat.1006432.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Jones</surname><given-names>JC</given-names></name>, <name><surname>Baranovich</surname><given-names>T</given-names></name>, <name><surname>Marathe</surname><given-names>BM</given-names></name>, <name><surname>Danner</surname><given-names>AF</given-names></name>, <name><surname>Seiler</surname><given-names>JP</given-names></name>, <name><surname>Franks</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Risk Assessment of H2N2 Influenza Viruses from the Avian Reservoir</article-title>. <source>J Virol</source>. <year>2014</year>;<volume>88</volume>(<issue>2</issue>):<fpage>1175</fpage>&#x02013;<lpage>88</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.02526-13">10.1128/JVI.02526-13</ext-link></comment>
<?supplied-pmid 24227848?><pub-id pub-id-type="pmid">24227848</pub-id></mixed-citation></ref><ref id="ppat.1006432.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Worobey</surname><given-names>M</given-names></name>, <name><surname>Han</surname><given-names>GZ</given-names></name>, <name><surname>Rambaut</surname><given-names>A</given-names></name>. <article-title>Genesis and pathogenesis of the 1918 pandemic H1N1 influenza A virus</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2014</year>;<volume>111</volume>(<issue>22</issue>):<fpage>8107</fpage>&#x02013;<lpage>12</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1324197111">10.1073/pnas.1324197111</ext-link></comment>
<?supplied-pmid 24778238?><pub-id pub-id-type="pmid">24778238</pub-id></mixed-citation></ref><ref id="ppat.1006432.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Gostic</surname><given-names>KM</given-names></name>, <name><surname>Ambrose</surname><given-names>M</given-names></name>, <name><surname>Worobey</surname><given-names>M</given-names></name>, <name><surname>Lloyd-Smith</surname><given-names>JO</given-names></name>. <article-title>Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting</article-title>. <source>Science</source>. <year>2016</year>;<volume>354</volume>(<issue>6313</issue>):<fpage>722</fpage>&#x02013;<lpage>726</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.aag1322">10.1126/science.aag1322</ext-link></comment>
<?supplied-pmid 27846599?><pub-id pub-id-type="pmid">27846599</pub-id></mixed-citation></ref><ref id="ppat.1006432.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Linderman</surname><given-names>SL</given-names></name>, <name><surname>Chambers</surname><given-names>BS</given-names></name>, <name><surname>Zost</surname><given-names>SJ</given-names></name>, <name><surname>Parkhouse</surname><given-names>K</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name>, <name><surname>Herrmann</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013&#x02013;2014 influenza season</article-title>. <source>Proceedings of the National Academy of Sciences</source>. <year>2014</year>;<volume>111</volume>(<issue>44</issue>):<fpage>15798</fpage>&#x02013;<lpage>15803</lpage>.</mixed-citation></ref><ref id="ppat.1006432.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>Y</given-names></name>, <name><surname>Myers</surname><given-names>JL</given-names></name>, <name><surname>Bostick</surname><given-names>DL</given-names></name>, <name><surname>Sullivan</surname><given-names>CB</given-names></name>, <name><surname>Madara</surname><given-names>J</given-names></name>, <name><surname>Linderman</surname><given-names>SL</given-names></name>, <etal>et al</etal>
<article-title>Immune history shapes specificity of pandemic H1N1 influenza antibody responses</article-title>. <source>J Exp Med</source>. <year>2013</year>
<month>7</month>;<volume>210</volume>(<issue>8</issue>):<fpage>1493</fpage>&#x02013;<lpage>500</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1084/jem.20130212">10.1084/jem.20130212</ext-link></comment>
<?supplied-pmid 23857983?><pub-id pub-id-type="pmid">23857983</pub-id></mixed-citation></ref><ref id="ppat.1006432.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Kucharski</surname><given-names>AJ</given-names></name>, <name><surname>Gog</surname><given-names>JR</given-names></name>. <article-title>Age profile of immunity to influenza: effect of original antigenic sin</article-title>. <source>Theor Popul Biol</source>
<year>2012</year>;<volume>81</volume>:<fpage>102</fpage>&#x02013;<lpage>112</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.tpb.2011.12.006">10.1016/j.tpb.2011.12.006</ext-link></comment>
<?supplied-pmid 22209755?><pub-id pub-id-type="pmid">22209755</pub-id></mixed-citation></ref><ref id="ppat.1006432.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Gagnon</surname><given-names>A</given-names></name>, <name><surname>Acosta</surname><given-names>JE</given-names></name>, <name><surname>Madrenas</surname><given-names>J</given-names></name>, <name><surname>Miller</surname><given-names>MS</given-names></name>. <article-title>Is Antigenic Sin Always &#x0201c;Original?&#x0201d; Re-examining the Evidence Regarding Circulation of a Human H1 Influenza Virus Immediately Prior to the 1918 Spanish Flu</article-title>. <source>PLoS Pathog</source>
<year>2015</year>;<volume>11</volume>:<fpage>e1004615</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.ppat.1004615">10.1371/journal.ppat.1004615</ext-link></comment>
<?supplied-pmid 25742615?><pub-id pub-id-type="pmid">25742615</pub-id></mixed-citation></ref><ref id="ppat.1006432.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Holmes</surname><given-names>EC</given-names></name>, <name><surname>Grenfell</surname><given-names>BT</given-names></name>. <article-title>Discovering the phylodynamics of RNA viruses</article-title>. <source>PLoS Comput Biol</source>
<year>2009</year>;<volume>5</volume>(<issue>10</issue>):<fpage>e1000505</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pcbi.1000505">10.1371/journal.pcbi.1000505</ext-link></comment>
<?supplied-pmid 19855824?><pub-id pub-id-type="pmid">19855824</pub-id></mixed-citation></ref><ref id="ppat.1006432.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Lessler</surname><given-names>J</given-names></name>, <name><surname>Cummings</surname><given-names>DAT</given-names></name>, <name><surname>Read</surname><given-names>JM</given-names></name>, <name><surname>Wang</surname><given-names>S</given-names></name>, <name><surname>Zhu</surname><given-names>H</given-names></name>, <name><surname>Smith</surname><given-names>GJD</given-names></name>, <etal>et al</etal>
<article-title>Location-specific patterns of exposure to recent pre-pandemic strains of influenza A in southern China</article-title>. <source>Nat Commun</source>
<year>2011</year>;<volume>2</volume>:<fpage>423</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ncomms1432">10.1038/ncomms1432</ext-link></comment>
<?supplied-pmid 21829185?><pub-id pub-id-type="pmid">21829185</pub-id></mixed-citation></ref></ref-list></back></article>